A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy
- PMID: 16446530
- DOI: 10.1159/000091189
A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy
Abstract
Background: The clinical presentation of hemoptysis often raises a number of diagnostic possibilities.
Objectives: This study was designed to evaluate the relative frequency of different causes of hemoptysis and the value of chest radiography, computed tomography (CT) scanning and fiber-optic bronchoscopy in the evaluation of a Greek cohort population.
Methods: We prospectively followed a total of 184 consecutive patients (137 males/47 females, 145 smokers/39 nonsmokers) admitted with hemoptysis between January 2001 and December 2003 to the University Hospital of Heraklion. Follow-up data were collected on August 2005.
Results: The main causes of hemoptysis were bronchiectasis (26%), chronic bronchitis (23%), acute bronchitis (15%) and lung cancer (13%). Bronchiectasis was significantly more frequent in nonsmokers (p < 0.02). Among nonsmokers, patients with moderate/severe bleeding or a history of tuberculosis were more likely to have bronchiectasis (OR 8.25; 95% CI 1.9-35.9, p = 0.007 and OR 16.5; 95% CI 1.7-159.1, p = 0.007, respectively). Nonsmokers with normal or abnormal X-rays were equally likely to have bronchiectasis (OR 2.5; 95% CI 0.66-9.39, p = 0.2). Lung cancer was only found in smokers. Smokers with normal X-rays were less likely to have lung cancer compared to smokers with abnormal X-ray (OR 5.4; 95% CI 1.54-19.34, p = 0.004). There were no smokers with normal CT and lung cancer. Follow-up data were collected in 91% of patients. Lung cancer did not develop in any patient assumed to have hemoptysis of another origin than lung cancer on initial evaluation.
Conclusions: Bronchiectasis is the main diagnosis in patients admitted with hemoptysis to a Greek University Hospital and it is more frequent among nonsmokers with moderate/severe bleeding and/or previous tuberculosis infection. Nonsmokers with moderate/severe hemoptysis and/or a history of tuberculosis should be evaluated with high-resolution CT. Smokers with hemoptysis are at increased risk for lung cancer and need to be extensively evaluated with chest CT and bronchoscopy.
Similar articles
-
[Usefulness of computerized tomography and bronchoscopy in patients with hemoptysis. Analysis of 482 cases].An Med Interna. 2002 Feb;19(2):59-65. An Med Interna. 2002. PMID: 11989098 Spanish.
-
[Utility of the clinical history, physical examination and radiography in the localization of bleeding in patients with hemoptysis].An Med Interna. 2002 Jun;19(6):289-95. An Med Interna. 2002. PMID: 12152387 Spanish.
-
[Frequency and causes of hemoptysis and role of bronchoscopy in patients with normal chest roentgenogram hospitalized in the Department of Physiopneumonology Silesian Medical University in the years 1961-1996].Pneumonol Alergol Pol. 2001;69(11-12):663-8. Pneumonol Alergol Pol. 2001. PMID: 12134443 Polish.
-
[Hemoptysis].Rev Prat. 2003 May 1;53(9):975-9. Rev Prat. 2003. PMID: 12816036 Review. French.
-
Diagnosis and management of hemoptysis.J La State Med Soc. 1994 Apr;146(4):115-8. J La State Med Soc. 1994. PMID: 8006494 Review.
Cited by
-
Bronchoscopic findings and bleeding control predict survival in patients with solid malignancies presenting with mild hemoptysis.Ann Am Thorac Soc. 2013 Aug;10(4):342-9. doi: 10.1513/AnnalsATS.201303-056OC. Ann Am Thorac Soc. 2013. PMID: 23952853 Free PMC article.
-
Management of an unusual cause of life-threatening haemoptysis: a multidisciplinary approach.BMJ Case Rep. 2021 May 20;14(5):e240448. doi: 10.1136/bcr-2020-240448. BMJ Case Rep. 2021. PMID: 34016628 Free PMC article.
-
Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series.Pulm Pharmacol Ther. 2020 Feb;60:101871. doi: 10.1016/j.pupt.2019.101871. Epub 2019 Nov 26. Pulm Pharmacol Ther. 2020. PMID: 31783097 Free PMC article.
-
A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis.BMC Pulm Med. 2022 Jun 2;22(1):214. doi: 10.1186/s12890-022-02006-x. BMC Pulm Med. 2022. PMID: 35650568 Free PMC article.
-
Bronchoscopy as a supplement to computed tomography in patients with haemoptysis may be unnecessary.Eur Clin Respir J. 2016 Jun 23;3:31802. doi: 10.3402/ecrj.v3.31802. eCollection 2016. Eur Clin Respir J. 2016. PMID: 27343164 Free PMC article.